Research summary
Ashwagandha and Salivary Hormones in Men
Quick answer
One small trial studied salivary hormone measurements in overweight men with mild fatigue. A hormone difference is distinct from improved symptoms or an established clinical benefit.[1]
What these findings do not establish
The studied extract delivered 21 mg of withanolide glycosides per day. Fifty-seven men enrolled, 50 completed the first eight weeks, and 43 completed the full 16-week crossover study. Fatigue, vigor, and sexual or psychological well-being did not improve significantly versus placebo; the salivary hormone findings do not establish a clinical benefit or effects in women.[1]
What does the evidence support?
Read each finding with its qualification. These are source-supported statements, not a ranking of products or personal treatment advice.
| Finding and qualification | References |
|---|---|
| In one small randomized placebo-controlled crossover trial of overweight men aged 40 to 70 years with mild fatigue, eight weeks of ashwagandha extract was associated with higher salivary testosterone and DHEA-S than placebo. The studied extract delivered 21 mg of withanolide glycosides per day. Fifty-seven men enrolled, 50 completed the first eight weeks, and 43 completed the full 16-week crossover study. Fatigue, vigor, and sexual or psychological well-being did not improve significantly versus placebo; the salivary hormone findings do not establish a clinical benefit or effects in women. | [1] |
The salivary-hormone trial and its limits
In one small randomized placebo-controlled crossover trial of overweight men aged 40 to 70 years with mild fatigue, eight weeks of ashwagandha extract was associated with higher salivary testosterone and DHEA-S than placebo. The studied extract delivered 21 mg of withanolide glycosides per day. Fifty-seven men enrolled, 50 completed the first eight weeks, and 43 completed the full 16-week crossover study. Fatigue, vigor, and sexual or psychological well-being did not improve significantly versus placebo; the salivary hormone findings do not establish a clinical benefit or effects in women.[1]
Relevant safety guidance
NCCIH advises people with hormone-sensitive prostate cancer to avoid ashwagandha because it may increase testosterone. This is a condition-specific safety caution, not a treatment recommendation or an instruction to change cancer care.[2]
Do higher salivary hormones establish a sexual-health benefit?
The crossover trial measured salivary testosterone and DHEA-S in overweight men aged 40–70 with mild fatigue. It did not find significant improvements versus placebo in fatigue, vigor, or sexual and psychological well-being. A hormone-marker result should not be substituted for a measured symptom benefit or generalized to young athletes, fertility, or women.[1]
Attrition also matters: 57 men enrolled, 50 completed the first eight weeks, and 43 completed the full crossover study. This small selected sample supports describing an exploratory laboratory signal, not promising testosterone treatment or using it to bypass assessment of symptoms. The hormone-sensitive-prostate-cancer caution remains separate from any potential benefit.[1], [2]
References
- A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha ( Withania somnifera) in Aging, Overweight Males.. American journal of men's health. 2019. Randomized controlled trial View source →
- Ashwagandha: Usefulness and Safety. NIH National Center for Complementary and Integrative Health. Retrieved 2026-09-30. Government health fact sheet View source →
Frequently asked questions
Does ashwagandha increase testosterone in men?
In one small crossover study of overweight men aged 40–70 with mild fatigue, eight weeks of supplementation was associated with higher salivary testosterone and DHEA-S than placebo. Fatigue, vigor and sexual well-being did not improve significantly versus placebo, so these hormone changes do not establish clinical benefit.
Read the full FAQ and limitations →